| Product Code: ETC7743379 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Neoantigens Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Neoantigens Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Neoantigens Market - Industry Life Cycle |
3.4 Japan Neoantigens Market - Porter's Five Forces |
3.5 Japan Neoantigens Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Japan Neoantigens Market Revenues & Volume Share, By Therapeutic Specialty, 2021 & 2031F |
3.7 Japan Neoantigens Market Revenues & Volume Share, By Line of Therapy, 2021 & 2031F |
3.8 Japan Neoantigens Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Japan Neoantigens Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development activities in the field of neoantigens |
4.2.2 Growing prevalence of cancer in Japan |
4.2.3 Rising investments in personalized medicine and immunotherapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory processes for neoantigen-based therapies |
4.3.2 High costs associated with neoantigen identification and development |
4.3.3 Limited awareness and adoption of neoantigen therapies among healthcare professionals and patients |
5 Japan Neoantigens Market Trends |
6 Japan Neoantigens Market, By Types |
6.1 Japan Neoantigens Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Japan Neoantigens Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Japan Neoantigens Market Revenues & Volume, By Combination Therapy, 2021- 2031F |
6.1.4 Japan Neoantigens Market Revenues & Volume, By Mono Therapy, 2021- 2031F |
6.2 Japan Neoantigens Market, By Therapeutic Specialty |
6.2.1 Overview and Analysis |
6.2.2 Japan Neoantigens Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.3 Japan Neoantigens Market Revenues & Volume, By Urinary System Cancer, 2021- 2031F |
6.2.4 Japan Neoantigens Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.2.5 Japan Neoantigens Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.6 Japan Neoantigens Market Revenues & Volume, By Head and Neck Cancer, 2021- 2031F |
6.2.7 Japan Neoantigens Market Revenues & Volume, By Blood and Bone Marrow Cancer, 2021- 2031F |
6.3 Japan Neoantigens Market, By Line of Therapy |
6.3.1 Overview and Analysis |
6.3.2 Japan Neoantigens Market Revenues & Volume, By First Line, 2021- 2031F |
6.3.3 Japan Neoantigens Market Revenues & Volume, By Second Line, 2021- 2031F |
6.3.4 Japan Neoantigens Market Revenues & Volume, By Later Lines, 2021- 2031F |
6.4 Japan Neoantigens Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Japan Neoantigens Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Japan Neoantigens Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Japan Neoantigens Market Revenues & Volume, By Specialty Centers, 2021- 2031F |
6.4.5 Japan Neoantigens Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Neoantigens Market Import-Export Trade Statistics |
7.1 Japan Neoantigens Market Export to Major Countries |
7.2 Japan Neoantigens Market Imports from Major Countries |
8 Japan Neoantigens Market Key Performance Indicators |
8.1 Number of clinical trials involving neoantigens in Japan |
8.2 Funding raised by companies focused on neoantigen therapies |
8.3 Number of partnerships and collaborations in the neoantigen market in Japan |
9 Japan Neoantigens Market - Opportunity Assessment |
9.1 Japan Neoantigens Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Japan Neoantigens Market Opportunity Assessment, By Therapeutic Specialty, 2021 & 2031F |
9.3 Japan Neoantigens Market Opportunity Assessment, By Line of Therapy, 2021 & 2031F |
9.4 Japan Neoantigens Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Japan Neoantigens Market - Competitive Landscape |
10.1 Japan Neoantigens Market Revenue Share, By Companies, 2024 |
10.2 Japan Neoantigens Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here